Topics

Evox Therapeutics and Takeda enter multi-target rare disease alliance

15:40 EDT 26 Mar 2020 | Elsevier Business Intelligence

Evox Therapeutics Ltd. and Takeda Pharmaceutical Co. Ltd. have partnered to develop up to five novel protein replacement and...

Original Article: Evox Therapeutics and Takeda enter multi-target rare disease alliance

NEXT ARTICLE

More From BioPortfolio on "Evox Therapeutics and Takeda enter multi-target rare disease alliance"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...